NASDAQ OMX

Unprecedented worldwide support for the Global Partnership for Education and addressing the global learning crisis

Dela

DAKAR, Senegal, Feb. 03, 2018 (GLOBE NEWSWIRE) -- Ten current and three former heads of state and more than 60 ministers gathered at the Global Partnership for Education (GPE) Financing Conference, making this the highest-level education financing event of its kind.

The conference, co-hosted by President Macky Sall of the Republic of Senegal and President Emmanuel Macron of the French Republic, marks the first time an education financing conference has been hosted by a G7 leader and the president of a developing country.

More than 1200 participants attended including leaders from UNESCO, UNICEF, the World Bank, civil society, philanthropic foundations and the private sector. Rihanna, GPE's Global Ambassador supported by Global Citizen, also participated.

The size and nature of the attendance at the conference was a visible demonstration of the strengthened global political will to ensure every child is in school and learning. This heightened momentum will enable the Global Partnership for Education to reach the goal of providing US$2 billion a year by 2020 for education planning and delivery to support children's learning in developing countries.

Donor countries pledged US$2.3 billion in financing to GPE. This is a substantial increase in funding compared to the US$1.3 billion contributed over the past three years. In addition, several donor countries have indicated their intention to pledge further funds over the course of the financing period.

The biggest source of education financing comes from developing countries themselves. More than 50 developing countries announced they would increase public expenditures for education for the period of 2018 to 2020 to a total of US$110 billion, compared to US$80 billion between 2015 and 2017.

GPE encourages developing countries to increase their share of education spending to 20% of their overall budget. Of those governments committing today, over two-thirds will have reached that goal by 2020.

"I am energized by the generosity and determination we have seen here today to ensure every child and young person has access to a quality education. After today's commitments, we are seeing a clear trend to seriously address the global learning crisis," said Julia Gillard, Board Chair of the Global Partnership for Education and former Prime Minister of Australia. "The success of the conference marks a turning point for global political support for education financing and brings a new breadth and depth to our partnership."

At the conference, the United Arab Emirates joined GPE, becoming the first Arab donor and pledging US$100 million. Senegal, in addition to pledging to increase its own expenditure on education, became GPE's first African donor. The Netherlands and Spain renewed their involvement, and China attended for the first time.

"The unprecedented support today means that the Global Partnership for Education can continue to focus on the most excluded and vulnerable children and work to extend assistance to up to 89 countries, which are home to 870 million children and 78 percent of the world's out-of-school children," said Alice Albright, Chief Executive Officer, Global Partnership for Education.

The Global Partnership for Education's funding model is a catalyst for education investment, working hand in hand with governments of low-income and lower middle-income countries to strengthen their education systems. The Global Partnership for Education supports governments to develop robust national education plans so that funds can then be channeled into their priority areas with confidence that they will contribute to improved quality of education for all children. 

The conference was sponsored by: Ecobank, the Pan African Bank; Fondation Sonatel; and Altissia, and supported by Girls Not Brides; Global Campaign for Education; Global Citizen; Malala Fund; ONE; Plan International; RESULTS; and Women Deliver.

Video: https://www.youtube.com/gpforeducation

Conference Online Media Center:  https://www.globalpartnership.org/funding/replenishment/gpe-replenishment-media

Media contact

Alexandra Humme, ahumme@globalpartnership.org, tel: + 1 202 492 8890

For more information on the work of the Global Partnership for Education visit:

www.globalpartnership.org 
facebook.com/globalpartnership
twitter.com/gpforeducation

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ba917718-02da-4e22-8af8-d9e0c51153da




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Global Partnership for Education via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16Pressmeddelande

London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h

SEMAFO Signs Underground Mining Services Contract with AUMS24.5.2018 14:00Pressmeddelande

MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) reports that it has signed a mining services contract with African Underground Mining Services ("AUMS") to provide turnkey mining services for Siou underground. AUMS is a well-known and reputable mining contractor with underground experience in Burkina Faso and across Africa. Under the mining services contract, AUMS will be responsible for supplying the mining fleet and a skilled labour force for Siou underground in addition to ensuring development, production and auxiliary services. SEMAFO will provide technical services including geology and engineering as well as leveraging the existing surface infrastructure at Mana. The mining services contract has a term of 70 months. The economic terms of the mining services contract are consistent with the economics presented in the Mana pre-feasibility study filed March 29, 2018 on SEDAR. Preparatory work has already commenced on Siou underground with full project deplo

Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors24.5.2018 13:00Pressmeddelande

- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the first patient has been dosed in a Phase 1, first-in human clinical trial of MCLA-158 in patients with solid tumors with an initial focus on metastatic colorectal cancer. The trial will be conducted in Europe, where several Clinical Trial Applications (CTAs) have been approved to date. The Company also announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for MCLA-158, which was accepted by the FDA in April 2018. With this acceptance, Merus plans to open additional sites for this trial in the United States. MCLA-158 is designed to bind to cancer stem cells expressing leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) and epidermal grow

PRA Named International Clinical Research Company of the Year24.5.2018 10:00Pressmeddelande

RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award. "This award celebrates excellence in the clinical research industry and we are honored to once again be recognized by our peers," said Colin Shannon, President and Chief Executive Officer. "This award is possible thanks to the incredibly talented PRA team members we have working around the world who are deeply committed to their work in bringing new and life-saving therapies to the patients who need them." PRA also swept the Clinical Research Associate and Clinical Trial Administrator categories capturing a total of 11 awards. These awards follow PRA's recognition earlier this month in the PharmaTimes Americas competition where PRA also received 11 awards, including Company of the Year. The PharmaTimes, International Cli

Immunicum AB: Inbjudan till investerarträff24.5.2018 08:00Pressmeddelande

Pressmeddelande 24 maj 2018 Immunicum AB: Inbjudan till investerarträff Immunicum AB (publ; IMMU.ST) meddelade i dag att bolaget kommer att anordna en investerarträff i Kalmar den 13 juni kl. 18:00 CEST. Carlos de Sousa, Immunicums VD, kommer att hålla en presentation av det dagsaktuella läget, och han och övriga i ledningen kommer vara tillgängliga för att svara på frågor. Kalmar Datum: Onsdag 13 juni 2018 Tid: 18:00 - 20:00 CEST Plats: Kalmar Slott, Kungsgatan 1, 392 33 Kalmar För att delta på träffen, skicka ett mejl till events@immunicum.com med ditt fullständiga namn. För ytterligare information kontakta: Carlos de Sousa, VD, Immunicum Telefon: +46 (0) 31 41 50 52 E-post: info@immunicum.com Michaela Gertz, Finanschef, Immunicum Telefon: +46 (0) 31 41 50 52 E-post: ir@immunicum.com Media Relations Gretchen Schweitzer och Joanne Tudorica Trophic Communications Telefon: +49 172 861 8540 E-post: ir@immunicum.com Om Immunicum AB (publ) Immunicum etablerar ett unikt angreppssätt inom im

Immunicum AB: Invitation to Investor Event24.5.2018 08:00Pressmeddelande

Press Release 24 May 2018 Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session. Kalmar Date: Wednesday, June 13, 2018 Time: 18:00 - 20:00 CEST Location: Kalmar Slott, Kungsgatan 1, 392 33 Kalmar To register to attend the event, please send an email to events@immunicum.com with your full name. For more information, please contact: Carlos de Sousa, CEO, Immunicum Telephone: +46 (0) 31 41 50 52 E-mail: info@immunicum.com Michaela Gertz, CFO, Immunicum Telephone: +46 70 926 17 75 E-mail: ir@immunicum.com Media Relations Gretchen Schweitzer and Joanne Tudorica Trophic Communications Telephone: +49 172 861 8540 E-mail: ir@immunicum.com About Immunicum AB (publ) Immunicum is establis

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum